Autocrine overexpression of CTGF maintains fibrosis: RDA analysis of fibrosis genes in systemic sclerosis

被引:147
作者
Shi-Wen, X
Pennington, D
Holmes, A
Leask, A
Bradham, D
Beauchamp, JR
Fonseca, C
du Bois, RM
Martin, GR
Black, CM
Abraham, DJ
机构
[1] UCL, Royal Free & Univ Coll, Sch Med, Ctr Rheumatol, London NW3 2PF, England
[2] Imperial Canc Res Fund, Lab Lymphocyte Mol Biol, London WC2A 3PX, England
[3] Imperial Coll, Sch Med, MRC, Ctr Clin Sci, London W12 0NN, England
[4] Royal Brompton Hosp, Imperial Coll, Sch Med, Interstitial Lung Dis Unit, London SW3 6LR, England
[5] FibroGen Inc, San Francisco, CA 94080 USA
关键词
systemic sclerosis; fibroblasts; CTGF; TGF beta; fibrosis;
D O I
10.1006/excr.2000.4972
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We have used representational difference analysis (RDA) to identify up-regulated genes in skin fibroblasts from fibrotic lesions obtained from patients with systemic sclerosis (scleroderma). RDA of cDNA libraries derived from fibroblasts from involved and uninvolved skin detected several differentially expressed genes. One such gene consistently up-regulated in scleroderma cells coded for human connective tissue growth factor (CTGF). Other studies described here show that the CTGF protein is readily detected in cultures of systemic sclerosis fibroblasts but was not detected in comparable normal cells. High levels of CTGF are also evident in biological fluids from patients with systemic sclerosis, TGF ss stimulates CTGF production in both normal and systemic sclerosis fibroblasts with the latter found to be higher producers. Moreover, an analysis of constitutive and TGF ss-induced CTGF gene activation showed altered and elevated transcriptional responses in systemic sclerosis cells compared with controls. CTGF stimulated a two-to threefold increase in proal(I) collagen and fibronectin synthesis by both dermal and lung fibroblasts in culture and promoted significant matrix remodeling of fibroblast-populated three-dimensional collagen lattices. A direct relation between the overexpression of CTGF and elevated collagen synthesis was suggested by the observation that transfection of a CMV-CTGF cDNA construct and protein expression in fibroblasts increased the transcription of a Col 1 alpha 2 promoter-reporter construct to levels seen in systemic sclerosis fibroblasts. Using Col 1 alpha 2 promoter deletion constructs the CTG;F responsive element was localized to the first 379 bp upstream of the transcriptional start site. These data indicate that there is an overexpression of CTGF in the systemic sclerosis cells, probably due to increased gene transcription, and suggest that the dysregulation of CTGF production is an important factor in fibroblast activation and the excessive deposition of collagen in systemic sclerosis, (C) 2000 academic Press.
引用
收藏
页码:213 / 224
页数:12
相关论文
共 39 条
[21]   GROWTH-REGULATION IN SCLERODERMA FIBROBLASTS - INCREASED RESPONSE TO TRANSFORMING GROWTH-FACTOR-BETA-1 [J].
KIKUCHI, K ;
KADONO, T ;
IHN, H ;
SATO, S ;
IGARASHI, A ;
NAKAGAWA, H ;
TAMAKI, K ;
TAKEHARA, K .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1995, 105 (01) :128-132
[22]   Inhibition of TGF-β-stimulated CTGF gene expression and anchorage-independent growth by cAMP identifies a CTGF-dependent restriction point in the cell cycle [J].
Kothapalli, D ;
Hayashi, N ;
Grotendorst, GR .
FASEB JOURNAL, 1998, 12 (12) :1151-1161
[23]  
Kothapalli D, 1997, CELL GROWTH DIFFER, V8, P61
[24]   The CCN family of angiogenic regulators: The integrin connection [J].
Lau, LF ;
Lam, SCT .
EXPERIMENTAL CELL RESEARCH, 1999, 248 (01) :44-57
[25]   INCREASED COLLAGEN-SYNTHESIS BY SCLERODERMA SKIN FIBROBLASTS INVITRO - POSSIBLE DEFECT IN REGULATION OR ACTIVATION OF SCLERODERMA FIBROBLAST [J].
LEROY, EC .
JOURNAL OF CLINICAL INVESTIGATION, 1974, 54 (04) :880-889
[26]   CLONING THE DIFFERENCES BETWEEN 2 COMPLEX GENOMES [J].
LISITSYN, N ;
LISITSYN, N ;
WIGLER, M .
SCIENCE, 1993, 259 (5097) :946-951
[27]   Thymosin β4 accelerates wound healing [J].
Malinda, KM ;
Sidhu, GS ;
Mani, H ;
Banaudha, K ;
Maheshwari, RK ;
Goldstein, AL ;
Kleinman, HK .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 113 (03) :364-368
[28]  
MCWHIRTER A, 1994, LAB INVEST, V71, P885
[29]  
Mori T, 1999, J CELL PHYSIOL, V181, P153, DOI 10.1002/(SICI)1097-4652(199910)181:1<153::AID-JCP16>3.0.CO
[30]  
2-K